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Abstract  
Introduction: Point-of-care hemoglobin testing devices can help emergency physicians to make their clinical 
decisions in a timelier manner.  They can also improve the patient care process by decreasing the length of stay 
and costs. Although different devices are available now, their diagnostic accuracy remains still uncertain.  
Objective: This study compares the results of hemoglobin levels measured by a point-of-care hemoglobin 
testing device and central lab auto-analyzer.  
Methods: Hemoglobin level was measured both by a point-of-care device (Mission® Plus Hb) and the central 
laboratory auto-analyzer (Sysmex KX-21N™) in medical cases presenting to emergency department (ED) and 
requiring hemoglobin (Hb)/hematocrit (Hct) level measurement. The agreement of Hb and Hct between the 
two methods was assessed based on intraclass correlation coinfection (ICC), Bland-Altman analysis and the 
Mountain plots. Also, time gap between point-of-care testing and preparation of central lab results was 
measured. 
Results: Hb and Hct were measured in 86 cases mostly presented because of gastrointestinal bleeding. We 
found a good agreement between the two methods for hemoglobin (ICC=0.985) and hematocrit levels 
(ICC=0.991). The bias was 0.09 and 95% limits of agreement (LoA) were -0.89 to 1.07 for Hb level. Mean of 
time delay between point-of-care testing and preparation of central lab results was 207.31 minutes (SD=93.66) 
and this delay was clinically significant (p=0.001). 
Conclusion: Point-of-care measurement of Hb level provides proper quantitative results in ED patients. It 
significantly decreases laboratory turnaround time and may be used to improve the patient throughput by 
decreasing the length of stay in most clinical settings. 
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INTRODUCTION
Laboratory data is used in between 40% to 70% of 
all medical decision makings (1, 2). Hemoglobin 
level measurement is the most common 
hematologic test used both in emergency 
department (ED) patients and a variety of other 
patients in outpatient and inpatient settings (3, 4). 
Hemoglobin is conventionally measured with 
central lab hematology auto-analyzers via a time-
consuming process. Currently, small portable 
point-of-care testing (POCT) devices, which are 
readily available in some countries (even in pre-
hospital settings), have provided the ability of 
continuous and spot-check measurement of 
hemoglobin level by different minimally invasive 
or noninvasive methods in a timelier manner (5-7).  
POCT has become more popular in routine medical 
practice and if it can provide consistent reliable 
bedside test results, it may help physicians to make 
more accurate decisions in a timelier manner. 
Controlled use of POCT devices in patients with 
clearly defined indications has the potential to 
spare the time of diagnostic procedures, decrease 
the length of stay in ED, decrease the costs for 
patient and hospital, increase the patient and 
personnel satisfaction and improve the overall 
patient care process (8). Although there are 
different POCT devices available now, the 
reliability of their test results is still a conflicting 
area. This study evaluated the agreement of a 
point-of-care Hb measurement device in 
comparison with automated central laboratory 
hematology analyzer in ED patients.  
Methods 
Study design and setting  
This single-center cross-sectional study was 
performed in an ED of a tertiary level referral 
teaching hospital with annual censuses of about 
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50,000 in Tehran, Iran. This hospital is a referral 
center for adult hematology/oncology cases older 
than 18 years old. We enrolled cases from May to 
December 2018 by convenience sampling. 
Institutional ethics committee approved the study 
(Code: IR.SBMU.MSP.REC.1396.315). Informed 
consent was obtained from all patients or their 
legal guardians.  
Participants and intervention 
We included patients with acute or chronic 
gastrointestinal/vaginal bleeding, chronic anemia 
with different indications for blood transfusion 
(like known cases of hematologic and oncologic 
disorders, chronic renal failure cases, etc.), patients 
presenting to the ED with chief complaints of 
weakness and syncope, any other cases that were 
admitted to the ED that required Hb level 
measurement. Because of the importance of the 
spot check and serial Hb level in decision making 
for trauma patients, they were included in another 
study conducted in a trauma center. Patients with 
hemoglobinopathies which affect the results of Hb 
level assessment and pregnant women were 
excluded from the study.  
Study protocol  
For all included patients, a point-of-care Hb 
measurement was performed by a single research 
assistant after taking a history and conducting a 
physical exam. Then a venous sample was sent to 
central lab for measuring the Hb level. 
Demographic data, patient’s chief complaint, point-
of-care and central lab test results and time gap 
between reading the POCT results and preparing 
the central lab ones were documented. 
Measurements 
All POCT measurements were carried out with 
Mission® Plus Hb (ACON Laboratories, Inc. USA). 
This is a small portable handheld device which 
measures a wide range of Hb (4.5 to 25.6 g/dl) and 
Hct (13% to 75%). The device is turned on and a 
test strip is inserted in. One of the fingers is 
punctured to collect 10 µL capillary blood via a tiny 
tube and transferred to the test strip. Hb level is 
first measured in this fixed pre-determined volume 
of blood and then the whole capillary blood Hb and 
Hct level is calculated automatically and displayed 
within 15 seconds. 
All central lab measurements were done by Sysmex 
KX-21N™ (Sysmex, Norderstedt, Germany) on 
venous blood samples.  
The Mission® Plus was checked every day using 
the control cuvette and a standard known 
concentration of Hb. Sysmex KX-21N™ was 
controlled in central lab in a daily basis by using 3 
standard control sets. 
Data analysis 
Variables were described with mean, minimum, 
maximum, frequency and percent. The Hb/Hct 
level values were described as mean ± standard 
deviation (SD). Mean difference of Hb/Hct was 
assessed with paired samples t-test. We assessed 
absolute agreement of Hb and Hct levels measured 
by POCT device and central lab automated analyzer 
with intraclass correlation coefficient (ICC). Also, 
we assessed of agreement between the two 
methods with Bland-Altman analysis and 
presented bias and 95% limits of agreement (Mean 
of differences ± 2 SD) with 95% CI for each. The 
Bland-Altman plot was drawn based on mean of 
both methods and differences in X and Y axes, 
respectively. Also, the mountain plot was 
generated to visualize the distribution of difference 
better. If the two methods are unbiased with 
respect to each other, the scatter plots should be 
centered over zero. P-value < 0.05 was considered 
statistically significant. 
RESULTS 
Baseline data 
Ninety patients were enrolled in the study. Four 
patients were excluded because of a failure in 
POCT. Hb level was very low (2.3, 3.4 and 3.5 g/dl) 
in three of these four patients and very high (27 
g/dl) in one of them as measured by automated 
hematology analyzer. Therefore, eighty-six cases 
were finally analyzed. Mean age of study patients 
was 60.37±16.9 years old with a minimum of 16 
and a maximum of 94. Other demographic data is 
summarized in table 1.  
Main results 
The mean (SD) of Hb-POCT and Hb-LAB was 10.12 
(2.89) and 10.03 (2.91), respectively and this 
difference was not significant (p=0.093). However, 
mean difference of Hct between the two methods (-
0.44) was statistically significant (p=0.001). The 
absolute agreement based on ICC was 0.98 and 
Table 1: Baseline data of study patients 
Variable Number (%) 
Sex  
Female  31 (36.0) 
Male  55 (64.0) 
Chief complaint  
Gastrointestinal bleeding 42 (48.8) 
Weakness 43 (50.0) 
 Known cases of cancer 13 (15.1) 
 Chronic anemia  28 (32.5) 
 Chronic renal failure 1 (1.1) 
 Cor pulmonale 1 (1.1) 
 Vaginal bleeding 2 (2.2) 
 Syncope  1 (1.1) 
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0.99 for Hb and Hct, respectively; which shows a 
high agreement between the two methods (Table 
2).  
Based on Bland-Altman analysis, bias of Hb levels 
was 0.09 (95% CI: -0.02 to 0.20) and 95% limits of 
agreement (LoA) was -0.89 to 1.07. Therefore, a 
very good agreement existed between Hb levels 
measured by POCT device and those by central lab 
automated analyzer and the bias was not 
significant (Figure 1). The bias of Hct levels was -
0.44 (95% CI: -0.68 to -0.20) and 95% limits of 
agreement was -2.6 to 1.70, and only four cases 
(4.65%) were out of 95% LoA (Figure 2). 
Therefore, the agreement of Hb between the two 
methods was a little better than that of Hct level. 
The Mountain Plot showed that the difference 
between the two methods was lower for Hb levels 
than that for Hct levels, and as the plot was 
centered over zero, it presented lower differences 
(Figures 1, 2). 
Mean of time delay between obtaining POC and 
central lab test results was 207.31±93.66 minutes 
(range: 64-571 minutes). By considering 60 
minutes as a limit for clinical importance and the 
difference in preparing the Hb level measurement 
by lab, the two methods used in this study were 
Table 2: Distribution, mean differences and ICC of Hb and Hct levels measured by POCT device and central lab automated analyzer 
(n=86) 
Variable Min, Max Mean (SD) P-value ICC (95% CI) 
Hb-POCT 4.50, 6.80 10.12 (2.89) - 0.985 
(0.977 to 0.990) Hb-LAB 4.70, 17.40 10.03 (2.91) - 
Two Hb levels difference 0.00, 1.70 0.092 (0.50) 0.093 - 
Hct-POCT 15.00, 54.00 30.87 (8.66) - 0.991 
(0.983 to 0.994) Hct-LAB 14.20, 56.00 31.30 (8.52) - 
Two Hct levels difference  0.00, 3.60 0.44 (1.11) 0.001 - 
CI: Confidence interval; Hb: hemoglobin; Hct: hematocrit; ICC: Intraclass correlation coinfection 
 
  
Figure 1: Bland-Altman plot (A) and the Mountain plots (B) of hemoglobin (Hb) levels measured by POCT device and central lab 
automated analyzer 
 
  
Figure 2: Bland-Altman plot (A) and the Mountain plots (B) of hematocrit (Hct) levels measured by POCT device and central lab 
automated analyzer 
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significantly different in preparing the results of Hb 
measurements (P=0.001). This means that the 
delays of central lab in measuring the Hb level may 
yield a negative impact on patients’ clinical course 
and outcome.  
DISCUSSION 
Our study showed that the Hb concentrations 
measured by Mission® Plus Hb using a fingerstick 
blood sample are comparable with results of 
central lab auto-analyzer. While an intraclass 
correlation coefficient of 1 indicates a perfect 
agreement between the two methods, coefficient 
between POCT and central lab Hb levels in our 
study was 0.985 and coefficient was even higher 
between POCT and central lab Hct levels (0.991). 
Our results revealed that time was dramatically 
saved by performing bedside tests with Mission® 
Plus Hb. 
 Our results are similar to those of Raikhel et al. 
who studied 152 adult patients presenting to an 
outpatient research clinic. These patients were 
tested for Hb measurement by 3 methods: 
noninvasive pulse co-oximetry, a POCT device 
(HemoCue201+®), and hematology analyzer of 
central lab. They showed that both noninvasive 
pulse co-oximetry and HemoCue 201+® provide 
accurate results in comparison with hematology 
auto-analyzer. The mechanism of action in 
HemoCue 201+® is similar to the device we used 
in our study. Both of them use finger-tip blood 
sample and use strips to collect and transfer the 
blood into the device, just like regular glucometers. 
Noninvasive SpHb® testing had bias and SD similar 
to those of HemoCue 201+®. In this study 
noninvasive pulse co-oximetry measurements 
were as accurate as central lab and POCT device 
and they may offer additional benefits for patient 
and providers, but there were also 4 cases of 
measurement failure in pulse co-oximetry group 
while all attempts were successful in measuring the 
Hb level by POCT device (9).  
In another study, Dolscheid-Pommerich et al. 
retrospectively compared the values of Hb 
measured by POCT device (System 
Rapidlab™1265) and central laboratory auto-
analyzer in 2548 patients in an emergency 
department. Point-of-care Hb measurement had 
been a common practice at this level I trauma 
center for years. They observed a highly significant 
(r=0.96, p<0.001) overall correlation between Hb 
levels measured by System Rapidlab™1265 and 
central lab auto-analyzer with a mean difference of 
-0.44g/dl. In samples with Hb<8 g/dl and also in 
very old patients (>85 years old), the difference 
between results of central lab and POCT device was 
not statistically significant (10). In a study on 
neonates, Rechner et al. showed that with adequate 
training and monitoring, the HemoCue which 
works like the device we used in our study can be 
used directly on the neonatal unit for rapid 
determination of Hb levels while it uses much less 
blood by collecting capillary blood sample from 
heel prick compared with that of the central 
laboratory (11). Bernard et al. also compared Hb 
levels measured by HemoCue and hematology 
analyzer in 398 cases. Comparing HemoCue to 
auto-analyzer in terms of Hb levels revealed a 
correlation coefficient of 0.99 and limit of 
agreement of -0.38 to -0.64 g/dl verifying that the 
results of Hb level assessments using HemoCue® 
device were comparable to those of automated 
hematology analyzer (12).  
In a study with 500 blood donors, venous Hb 
concentrations were measured by hematology 
analyzer and capillary Hb level was measured by 
fingertip or earstick blood sample. This study 
showed that hemoglobin levels measured by 
HemoCue and finger-tip blood were higher than 
those measured by central lab in venous samples as 
their differences exceed the limit of 1g/dl in 9% of 
samples tested by HemoCue. Accordingly, Hb levels 
measured by HemoCue and ear-stick samples were 
significantly higher than the actual hemoglobin 
concentration (13). 
HemoCue POCT device was also used in another 
study by Adam et al. in Sudan. They measured Hb 
level by HemoCue in 108 pregnant women with 2 
methods of blood sampling (venous blood, 
capillary blood). Venous blood samples were 
collected by special vacutainer tubes and capillary 
blood samples were obtained from middle finger-
tip of left hand.  In this study, there was no 
agreement between Hb levels measured by 
HemoCue® and automated hematology analyzer. 
The mean±SD of hemoglobin levels were 
12.70±1.77 measured by HemoCue® with venous 
blood samples, 12.87±2.04 measured by 
HemoCue® and 11.53±1.63 measured by 
hematology analyzer (14). In another study by 
Seguin et al., Hb values were determined using the 
portable HemoCue system and central lab analyzer. 
In their study, 150 samples were obtained from 79 
adult patients hospitalized in surgical intensive 
care unit. Hb level was measured by HemoCue and 
compared to the results of central lab assessments 
done on the simultaneously obtained sample. The 
mean absolute differences between Hb-Lab and 
HemoCue were 1.1 g/dl (95%CI, -3.6 to + 5.8 g/dl). 
They concluded that HemoCue could not determine 
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the level of Hb accurately in critically ill patients 
and suggested that peripheral edema may affect 
the accuracy of results predominantly (15).  
Several other studies found some limitations in 
using POCT devices in general daily practice. Kim 
SH et al. evaluated a total of 32 studies in a meta-
analysis and reported that although the mean 
difference between noninvasive and central 
laboratory measurements was small, the limits of 
agreement were wide, which means that clinicians 
should cautiously make clinical decisions based on 
POCT devices. In their meta-analysis, mean 
difference and SD were 0.10±1.37 g/dl while we 
had a mean difference of 0.09 and SD of 0.33 in our 
study (16). Hiscock R. et al. assessed the agreement 
between POCT hemoglobin measurements with 
laboratory-based one in 39 studies. They found 
also wide limits of agreement (-1.3 to 1.4 g/dl) and 
concluded that clinicians should carefully consider 
these limits of agreement before making clinical 
decisions about transfusion on point-of-care 
measurements alone (17).  
Some studies emphasize general disadvantages of 
POCT like the lack of universal standard training 
for obtaining blood samples and/or calibration of 
the devices and insufficient internal and external 
quality assessments. These studies show that POCT 
should be used with certain indications under clear 
and tight institutional regulations to ensure patient 
safety and oversee other disadvantages (18-20). 
Limitations  
Hb measurement by fingertip capillary blood 
collection is still an invasive method. It provides 
just a spot check intermittent monitoring of Hb 
level. Our study showed POCT device significantly 
saved time, but it is not determined if this decrease 
in time improved patient outcomes or not. 
Complementary outcome studies are needed to 
assess the true impact of POCT on patient care. 
Small sample size was another limitation in our 
study, so studies with larger sample sizes will be 
beneficial in determining the agreement and 
accuracy of POCT measurements in emergency 
department. We had just one operator in our study 
that performed all 90 measurements; it is 
recommended that studies with a larger sample 
size employ multiple operators to improve the 
generalization of results. 
CONCLUSIONS 
Point of care measurement of Hb level by Mission® 
Plus Hb provides proper quantitative results in 
emergency department patients. It decreases 
laboratory turnaround time significantly and may 
be used to improve the patient throughput by 
decreasing the length of stay in most clinical 
settings. 
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